RIP - A NOVEL PROTEIN CONTAINING A DEATH DOMAIN THAT INTERACTS WITH FAS/APO-1 (CD95) IN YEAST AND CAUSES CELL-DEATH

被引:870
作者
STANGER, BZ
LEDER, P
LEE, TH
KIM, E
SEED, B
机构
[1] HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA
[2] MASSACHUSETTS GEN HOSP, DEPT MOLEC BIOL, BOSTON, MA 02114 USA
关键词
D O I
10.1016/0092-8674(95)90072-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ligation of the extracellular domain of the cell surface receptor Fas/APO-1 (CD95) elicits a characteristic programmed death response in susceptible cells. Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Pas: Pas itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein. RIP also interacts weakly with the p55 tumor necrosis factor receptor (TNFR1) intracellular domain, but not with a mutant version of Pas corresponding to the murine lpr(cg) mutation. RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the Pas and TNFR1 intracellular domains. Transient overexpression of RIP causes transfected cells to undergo the morphological changes characteristic of apoptosis. Taken together, these properties indicate that RIP is a novel form of apoptosis-inducing protein.
引用
收藏
页码:513 / 523
页数:11
相关论文
共 56 条
  • [1] FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    ARMITAGE, RJ
    MARASKOVSKY, E
    TOUGH, TW
    ROUX, E
    SCHOOLEY, K
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2231 - 2235
  • [2] BASIC LOCAL ALIGNMENT SEARCH TOOL
    ALTSCHUL, SF
    GISH, W
    MILLER, W
    MYERS, EW
    LIPMAN, DJ
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) : 403 - 410
  • [3] SELF-ASSOCIATION OF THE DEATH DOMAINS OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND FAS/APO1 PROMPTS SIGNALING FOR TNF AND FAS/APO1 EFFECTS
    BOLDIN, MP
    METT, IL
    VARFOLOMEEV, EE
    CHUMAKOV, I
    SHEMERAVNI, Y
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 387 - 391
  • [4] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [5] FAS AND TUMOR-NECROSIS-FACTOR RECEPTOR-MEDIATED CELL-DEATH - SIMILARITIES AND DISTINCTIONS
    CLEMENT, MV
    STAMENKOVIC, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) : 557 - 567
  • [6] CRISPE IN, 1994, IMMUNITY, V1, P347
  • [7] DHEIN J, 1992, J IMMUNOL, V149, P3166
  • [8] EISCHEN CM, 1994, J IMMUNOL, V153, P1947
  • [9] ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT
    EVAN, GI
    LEWIS, GK
    RAMSAY, G
    BISHOP, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3610 - 3616
  • [10] A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY
    FEINBERG, AP
    VOGELSTEIN, B
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) : 6 - 13